Bullboard Post History

by PsilocybinAlpha

Order by:

MNMD	MindMed's LSD Neutralizer Study Explained... Your Brief MindMed has commenced a study for its “LSD neutralizer... February 17, 2021
MNMD	Microdose Division Expansion Your Brief Full News Release Here MindMed announced a randomised, placebo... January 12, 2021
CMPS	Interview: Lars Wilde, Co-founder of COMPASS Pathways We spoke to Lars Wilde, President, Chief Business Officer and Co-founder of... December 13, 2020
C.BRAX	Champignon CFO Resigns, Interim CFO Appointed The Company’s current contract CFO has resigned from the position, effective&... December 8, 2020
GTSIF	Lobe's Nasal Mist Lobe becomes the latest psychedelic company to explore delivery mechanisms... December 3, 2020
C.FTRP	FTRP investor update - Expanded Hours at its Field Trip Health Center in Toronto - Rollout of... December 3, 2020
C.FTRP	Field Trip Reports Q2 '20 Financials, $14m cash position Full financials November 30, 2020
C.FTRP	Q2 Results Nov 30; Conference Call Dec 1st 8am ET The Company will conduct a conference call and webcast to review its results... November 25, 2020
MNMD	MindMed to Launch Albert, A Digital Medicine Division MindMed to Launch Albert, A Digital Medicine Division for Psychedelic... November 24, 2020
T.NUMI	Numinus announces trial of psilocybin for substance use Numinus has announced it will undertake a compassionate access clinical... November 18, 2020
C.RVV	RVV Research Collab with PharmaTher: psilocybin for Cancer Revive Therapeutics Announces Research Collaboration with PharmaTher for... November 18, 2020
C.FTRP	Field Trip to Open Health Center in Amsterdam, March 2021 Field Trip Announces Expansion to The Netherlands and Launch of Proprietary... November 17, 2020
MNMD	MindMed Provides Updates on Trials, Interim Results Q1 2021 Full news here Your Brief MindMed provides an update on its... November 16, 2020
V.LNGE	MCUR Announces $3m Private Placement Mind Cure Announces Non-Brokered Private Placement of $3 Million Release here... November 13, 2020
CMPS	CMPS Q3 2020 Financial Results Third quarter and post-period highlights: ... November 12, 2020
C.BRAX	Champignon opens second clinic in Ontario, in Toronto Canadian Rapid Treatment Center of Excellence Opens Second Location Providing... November 9, 2020
C.FTRP	Renderings of Field Trip's Jamaica Facility Field Trip Health has shared renderings of their Jamaican facility with... November 4, 2020
MNMD	MindMed Closes Upsized Financing of CAD $28.75m MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional... October 30, 2020
T.NUMI	Numinus Harvests Psilocybe Mushrooms Numinus has become the first public company to harvest a legal flush of... October 22, 2020
C.PHRM	Pharmather Files for FDA Orphan Drug Designation Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson’s... October 20, 2020

Become a member today, It's free!

Bullboard Post History

by PsilocybinAlpha

MindMed's LSD Neutralizer Study Explained...

Microdose Division Expansion

Interview: Lars Wilde, Co-founder of COMPASS Pathways

Champignon CFO Resigns, Interim CFO Appointed

Lobe's Nasal Mist

FTRP investor update

Field Trip Reports Q2 '20 Financials, $14m cash position

Q2 Results Nov 30; Conference Call Dec 1st 8am ET

MindMed to Launch Albert, A Digital Medicine Division

Numinus announces trial of psilocybin for substance use

RVV Research Collab with PharmaTher: psilocybin for Cancer

Field Trip to Open Health Center in Amsterdam, March 2021

MindMed Provides Updates on Trials, Interim Results Q1 2021

MCUR Announces $3m Private Placement

CMPS Q3 2020 Financial Results

Champignon opens second clinic in Ontario, in Toronto

Renderings of Field Trip's Jamaica Facility

MindMed Closes Upsized Financing of CAD $28.75m

Numinus Harvests Psilocybe Mushrooms

Pharmather Files for FDA Orphan Drug Designation

Featured Company

Star Diamond Corp T.DIAM

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by PsilocybinAlpha

Featured Company